Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 2,020.00
+20.00 (1.00%)
Dec 11, 2025, 3:30 PM KST
Yungjin Pharm. Market Cap
Yungjin Pharm. has a market cap or net worth of 369.44 billion as of December 11, 2025. Its market cap has decreased by -1.70% in one year.
Market Cap
369.44B
Enterprise Value
n/a
Revenue
158.79B
Ranking
n/a
PE Ratio
37.76
Stock Price
2,020.00
Market Cap Chart
Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 369.44B, an increase of 497.77%. That is a compound annual growth rate of 5.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 365.78B | 0.60% |
| Dec 30, 2024 | 363.59B | -6.45% |
| Dec 28, 2023 | 388.65B | -34.62% |
| Dec 29, 2022 | 594.40B | -38.56% |
| Dec 30, 2021 | 967.50B | -34.20% |
| Dec 30, 2020 | 1.47T | 21.27% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.07T |
| Celltrion | 40.63T |
| ALTEOGEN | 24.41T |
| ABL Bio | 11.19T |
| SK Biopharmaceuticals | 10.66T |
| Yuhan | 8.65T |
| LigaChem Biosciences | 6.88T |
| Peptron | 6.54T |